What's new

Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 10, Status: Authorised

Mar 4, 2025 - 16:50
 0
Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ibandronic acid Accord...

Next Article

Over 16,000 Medium- and Heavy-Duty ZEV Charging & Fueling Points Available In Ca...

Related Posts

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Omvoh, Mirikizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0534/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0